Published in Cell Death Differ on September 19, 2014
CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA. Mol Cancer (2015) 0.97
miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets. Mol Cell Endocrinol (2015) 0.94
Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21. Oncotarget (2015) 0.91
Anti-CD73 in cancer immunotherapy: awakening new opportunities. Trends Cancer (2016) 0.90
Exosome Biogenesis, Regulation, and Function in Viral Infection. Viruses (2015) 0.90
Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells. Oncogene (2016) 0.84
A principle of organization which facilitates broad Lamarckian-like adaptations by improvisation. Biol Direct (2015) 0.83
Cardiac progenitor cell-derived exosomes prevent cardiomyocytes apoptosis through exosomal miR-21 by targeting PDCD4. Cell Death Dis (2016) 0.81
Exosomes: Potential in Cancer Diagnosis and Therapy. Medicines (Basel) (2015) 0.80
Microguards and micromessengers of the genome. Heredity (Edinb) (2015) 0.80
Roles for miRNAs in endocrine resistance in breast cancer. Endocr Relat Cancer (2015) 0.80
CLL Exosomes Modulate the Transcriptome and Behaviour of Recipient Stromal Cells and Are Selectively Enriched in miR-202-3p. PLoS One (2015) 0.80
Exosomes Derived from Mesenchymal Stromal Cells Promote Axonal Growth of Cortical Neurons. Mol Neurobiol (2016) 0.80
Understanding microRNA-mediated gene regulatory networks through mathematical modelling. Nucleic Acids Res (2016) 0.78
CD99 regulates neural differentiation of Ewing sarcoma cells through miR-34a-Notch-mediated control of NF-κB signaling. Oncogene (2015) 0.78
MicroRNAs--getting the hang of it. Cell Death Differ (2015) 0.77
Recapitulating the Size and Cargo of Tumor Exosomes in a Tissue-Engineered Model. Theranostics (2016) 0.77
Isolation and characterization of vesicular and non-vesicular microRNAs circulating in sera of partially hepatectomized rats. Sci Rep (2016) 0.76
Exosomes: novel implications in diagnosis and treatment of gastrointestinal cancer. Langenbecks Arch Surg (2016) 0.76
Biobanking of Exosomes in the Era of Precision Medicine: Are We There Yet? Int J Mol Sci (2015) 0.76
Plant derived edible nanoparticles as a new therapeutic approach against diseases. Tissue Barriers (2016) 0.76
Transferring intercellular signals and traits between cancer cells: extracellular vesicles as "homing pigeons". Cell Commun Signal (2016) 0.76
Emerging applications of exosomes in cancer therapeutics and diagnostics. Bioeng Transl Med (2017) 0.75
Milk exosomes: beyond dietary microRNAs. Genes Nutr (2017) 0.75
FRTL-5 Rat Thyroid Cells Release Thyroglobulin Sequestered in Exosomes: A Possible Novel Mechanism for Thyroglobulin Processing in the Thyroid. J Thyroid Res (2016) 0.75
Exosomes and breast cancer: a comprehensive review of novel therapeutic strategies from diagnosis to treatment. Cancer Gene Ther (2016) 0.75
Urinary Exosomal miR-193a Can Be a Potential Biomarker for the Diagnosis of Primary Focal Segmental Glomerulosclerosis in Children. Biomed Res Int (2017) 0.75
Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma. Sci Rep (2016) 0.75
Extracellular vesicles-mediated noncoding RNAs transfer in cancer. J Hematol Oncol (2017) 0.75
Cellular evidence for nano-scale exosome secretion and interactions with spermatozoa in the epididymis of the Chinese soft-shelled turtle, Pelodiscus sinensis. Oncotarget (2016) 0.75
The Importance of Standardization on Analyzing Circulating RNA. Mol Diagn Ther (2016) 0.75
Exosomes in colorectal carcinoma formation: ALIX under the magnifying glass. Mod Pathol (2016) 0.75
Discovering MicroRNA-Regulatory Modules in Multi-Dimensional Cancer Genomic Data: A Survey of Computational Methods. Cancer Inform (2016) 0.75
Carcinogenic activity of PbS quantum dots screened using exosomal biomarkers secreted from HEK293 cells. Int J Nanomedicine (2015) 0.75
Comparative Gene Expression Analysis of Lymphocytes Treated with Exosomes Derived from Ovarian Cancer and Ovarian Cysts. Front Immunol (2017) 0.75
Extracellular vesicles are independent metabolic units with asparaginase activity. Nat Chem Biol (2017) 0.75
Understanding the Role of Non-Coding RNAs in Bladder Cancer: From Dark Matter to Valuable Therapeutic Targets. Int J Mol Sci (2017) 0.75
The new era of nanotechnology, an alternative to change cancer treatment. Drug Des Devel Ther (2017) 0.75
Hallmarks of cancer: the next generation. Cell (2011) 140.01
MicroRNA signatures in human cancers. Nat Rev Cancer (2006) 46.29
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol (2007) 37.10
Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A (2008) 33.65
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol (2008) 19.86
Membrane vesicles as conveyors of immune responses. Nat Rev Immunol (2009) 14.72
MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell (2003) 14.07
Exosomes: composition, biogenesis and function. Nat Rev Immunol (2002) 13.99
miRNAs, cancer, and stem cell division. Cell (2005) 12.15
Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem (2010) 12.06
MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol (2008) 11.46
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med (2012) 11.14
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol (2011) 9.68
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ (2011) 9.44
Exosomes--vesicular carriers for intercellular communication. Curr Opin Cell Biol (2009) 6.96
Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med (1998) 6.36
Characterization of extracellular circulating microRNA. Nucleic Acids Res (2011) 6.24
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med (2001) 5.71
Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol (2009) 5.44
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci (2011) 5.42
Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer (2009) 5.11
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci U S A (2012) 5.07
Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer. Nat Clin Pract Oncol (2006) 4.91
Malignant effusions and immunogenic tumour-derived exosomes. Lancet (2002) 4.91
Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J Cell Biol (1999) 4.87
Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell (2014) 4.53
The biogenesis and functions of exosomes. Traffic (2002) 4.49
Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov (2013) 4.35
MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci U S A (2008) 4.33
Exosomes: proteomic insights and diagnostic potential. Expert Rev Proteomics (2009) 4.27
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol (2010) 4.06
Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene (2012) 3.83
ExoCarta: A compendium of exosomal proteins and RNA. Proteomics (2009) 3.72
MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov (2013) 3.33
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One (2010) 3.23
Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ (2007) 3.22
Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. J Immunol (2006) 3.12
An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat Neurosci (2012) 2.90
The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. Semin Cancer Biol (2011) 2.83
Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer. Br J Cancer (2009) 2.76
HER2 therapy: molecular mechanisms of trastuzumab resistance. Breast Cancer Res (2006) 2.74
Changes in circulating microRNA levels associated with prostate cancer. Br J Cancer (2012) 2.74
Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol Cancer (2011) 2.56
MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene (2006) 2.47
Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface. J Immunol (2000) 2.36
Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genomics (2013) 2.27
Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther (2012) 2.15
Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet (2012) 2.13
Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med (Berl) (2013) 2.12
The multifaceted exosome: biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities. Biochem Pharmacol (2011) 2.03
Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. J Immunol Methods (2001) 2.01
Early detection of breast cancer based on gene-expression patterns in peripheral blood cells. Breast Cancer Res (2005) 2.00
MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways. Traffic (2009) 1.98
MicroRNA-containing T-regulatory-cell-derived exosomes suppress pathogenic T helper 1 cells. Immunity (2014) 1.95
Cell to cell signalling via exosomes through esRNA. Cell Adh Migr (2007) 1.95
Exosomes: Fit to deliver small RNA. Commun Integr Biol (2010) 1.93
Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments. Semin Immunopathol (2011) 1.93
Metastatic stem cells: sources, niches, and vital pathways. Cell Stem Cell (2014) 1.88
Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia. Blood (2013) 1.87
Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease. Cancer Res (2009) 1.86
Extracellular miRNAs: the mystery of their origin and function. Trends Biochem Sci (2012) 1.82
Exosome-mediated delivery of siRNA in vitro and in vivo. Nat Protoc (2012) 1.70
Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha. PLoS One (2009) 1.70
miR-155: an ancient regulator of the immune system. Immunol Rev (2013) 1.68
Gene expression profiling of peripheral blood cells for early detection of breast cancer. Breast Cancer Res (2010) 1.64
Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes. Nucleic Acids Res (2012) 1.60
Circulating MicroRNA Signatures of Tumor-Derived Exosomes for Early Diagnosis of Non-Small-Cell Lung Cancer. Clin Lung Cancer (2009) 1.60
Exosomes from breast cancer cells can convert adipose tissue-derived mesenchymal stem cells into myofibroblast-like cells. Int J Oncol (2011) 1.55
Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a Src-dependent fashion. Angiogenesis (2011) 1.53
Exosomal tumor microRNA modulates premetastatic organ cells. Neoplasia (2013) 1.49
Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma. Br J Cancer (2013) 1.48
Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy. J Cell Physiol (2012) 1.45
Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection. J Immunol (2004) 1.43
Identifying mRNA, microRNA and protein profiles of melanoma exosomes. PLoS One (2012) 1.43
Human tumor nanoparticles induce apoptosis of pancreatic cancer cells. FASEB J (2008) 1.36
Highlights of a new type of intercellular communication: microvesicle-based information transfer. Inflamm Res (2009) 1.34
FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma. Imaging Med (2012) 1.32
Survivin is released from cancer cells via exosomes. Apoptosis (2011) 1.25
Microparticles in angiogenesis: therapeutic potential. Circ Res (2011) 1.24
Exosome removal as a therapeutic adjuvant in cancer. J Transl Med (2012) 1.24
Essential role of Notch signaling in apoptosis of human pancreatic tumoral cells mediated by exosomal nanoparticles. Int J Cancer (2009) 1.22
Exosomes are natural carriers of exogenous siRNA to human cells in vitro. Cell Commun Signal (2013) 1.20
Extracellular vesicles--vehicles that spread cancer genes. Bioessays (2012) 1.19
Exosome-mediated shuttling of microRNA-29 regulates HIV Tat and morphine-mediated neuronal dysfunction. Cell Death Dis (2012) 1.19
Efficient induction of antitumor T cell immunity by exosomes derived from heat-shocked lymphoma cells. Eur J Immunol (2006) 1.19
Tumour-derived exosomes or microvesicles: another mechanism of tumour escape from the host immune system? Br J Cancer (2005) 1.17
Gastric cancer exosomes trigger differentiation of umbilical cord derived mesenchymal stem cells to carcinoma-associated fibroblasts through TGF-β/Smad pathway. PLoS One (2012) 1.17
Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells. Eur J Cancer (2013) 1.16
Exosomes and immune surveillance of neoplastic lesions: a review. Biotech Histochem (2012) 1.12
Exosomes in tumour immunity. Curr Oncol (2009) 1.10
Surface anchorage of superantigen SEA promotes induction of specific antitumor immune response by tumor-derived exosomes. J Mol Med (Berl) (2007) 1.07
miR-155 inhibition sensitizes CD4+ Th cells for TREG mediated suppression. PLoS One (2009) 1.04
PET imaging of inflammation biomarkers. Theranostics (2013) 1.04
Dendritic cell-derived exosomes stimulate stronger CD8+ CTL responses and antitumor immunity than tumor cell-derived exosomes. Cell Mol Immunol (2006) 1.02
Proteome profiling of neuroblastoma-derived exosomes reveal the expression of proteins potentially involved in tumor progression. PLoS One (2013) 1.02
Metastasis. Exosomes drive premetastatic niche formation. Nat Rev Cancer (2012) 1.01
Shedding from normal and cancer-cell surfaces. N Engl J Med (1980) 1.01
Bladder cancer cell-derived exosomes inhibit tumor cell apoptosis and induce cell proliferation in vitro. Mol Med Rep (2013) 0.96
Exosome-based immunotherapy. Cancer Immunol Immunother (2004) 0.96
Dexosomes as a therapeutic cancer vaccine: from bench to bedside. Blood Cells Mol Dis (2005) 0.93